The results showed that the median time to first diabetic macular oedema resolution in the DEX group was 9.0 months [95% CI: ...

As July concludes, the landscape of hematologic oncology continues to evolve, with notable progress in multiple myeloma, ...

Every week, the TDN posts a roundup of the relevant Horseracing Integrity and Safety Act (HISA) related rulings from around the country. The following rulings were reported on HISA's “rulings” portal ...

The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug, Blenrep, as a combination treatment ...

The U.S. FDA's panel of independent advisers on Thursday recommended against GSK's blood cancer drug Blenrep, citing concerns ...

Most Oncologic Drugs Advisory Committee members took issue with the lack of dosing optimization and the lack of US patient ...

Maybe you've heard of "cortisol face," or "cortisol belly" or read that yoga and meditation can help lower your cortisol levels, but what does that really mean? Cortisol is a hormone made by ...

The comeback story of belantamab mafodotin (Blenrep) hit a roadblock Thursday as the FDA's Oncologic Drugs Advisory Committee ...

A multidrug regimen containing brentuximab vedotin (BV, Adcetris) proved feasible for older patients with advanced classical ...

Patients have been asking me about a recently published article that suggests a "'potential cure"' for myeloma is at hand.

The EU approves belantamab mafodotin combinations, enhancing treatment options for relapsed multiple myeloma patients with ...

Panelists discuss how patients newly diagnosed with multiple myeloma often face emotional and informational overload, but ...